Correction to: Genome Editing of Pik3cd Impedes Abnormal Retinal Angiogenesis,by Wu et al. Hum Gene Ther 2023;34(1-2):30-41;doi: 10.1089/hum.2022.079

In the January 2023 issue of Human Gene Therapy (vol. 34, no. 1-2; 30–41), the article titled Genome Editing of Pik3cd Impedes Abnormal Retinal Angiogenesis, by Wu et al. requires correction.

The Funding Information section was originally published as:

“This work was supported by the National Natural Science Foundation of China (82070989) to H.L.; the Sanming Project of Medicine in Shenzhen (SZSM202011015) to Y.X., G.Z., S.Z., and H.L.; the China Scholarship Council to W.W.; the Central South University student innovation project 2016zzts148 to W.W.; the National Natural Science Foundation of China (81900893, 8227109) to W.W.; and the Science and Technology Plan Project of Hunan Province (2019RS2011) to W.W. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the article.”

The Funding Information section should have appeared as:

“This work was supported by National Natural Science Foundation of China (82070989) to H.L.; Shenzhen Science and Technology Program, China (JCYJ20200109145001814) to Y.X. and H.L. ; Sanming Project of Medicine in Shenzhen (SZSM202011015) to Y.X., G.Z., S.Z., and H.L.; China Scholarship Council to W.W.; Central South University student innovation project 2016zzts148 to W.W.; National Natural Science Foundation of China (81900893, 8227109) to W.W.; and the Science and Technology Plan Project of Hunan Province (2019RS2011) to W.W. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the article.”

The online version of the article has been corrected to reflect this. The authors apologize for the error.